MedTrace Logo

Detemir Energy Expenditure Study

NCT00788840 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-05-31

No results posted yet for this study

Summary

This is a study designed to compare the effects of 2 long-acting insulins, detemir and insulatard, on energy expenditure,weight, fat composition, gut hormone profiles, glycaemic control and fat and muscle gene expression over a 6 month period.

Conditions

Interventions

DRUG

Insulatard

Insulatard insulin used as long-acting insulin for 16-week treatment phase of study.

DRUG

Detemir

Detemir insulin used as long-acting insulin in treatment phase of study.

Sponsors & Collaborators

Principal Investigators

  • David Russell-Jones, MB BS · University of Surrey

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00788840 on ClinicalTrials.gov